685,699 Shares in Agilent Technologies, Inc. $A Acquired by Freestone Grove Partners LP

Freestone Grove Partners LP purchased a new position in Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, HoldingsChannel.com reports. The firm purchased 685,699 shares of the medical research company’s stock, valued at approximately $91,081,000.

Several other institutional investors also recently modified their holdings of the stock. Core Wealth Advisors LLC bought a new stake in shares of Agilent Technologies during the 4th quarter worth $26,000. SHP Wealth Management acquired a new stake in shares of Agilent Technologies during the fourth quarter worth $26,000. Navalign LLC acquired a new stake in shares of Agilent Technologies during the fourth quarter worth $27,000. Cedar Mountain Advisors LLC purchased a new stake in shares of Agilent Technologies during the first quarter valued at $27,000. Finally, MV Capital Management Inc. purchased a new stake in shares of Agilent Technologies during the fourth quarter valued at $28,000.

Agilent Technologies Stock Performance

Shares of A stock opened at $155.16 on Thursday. The company has a market capitalization of $43.82 billion, a price-to-earnings ratio of 31.16, a P/E/G ratio of 2.73 and a beta of 1.25. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.51. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The stock’s fifty day simple moving average is $139.16 and its 200-day simple moving average is $126.65.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the prior year, the business earned $1.37 EPS. The business’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 6.05 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. Morgan Stanley upped their price objective on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Robert W. Baird raised their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. Sanford C. Bernstein initiated coverage on shares of Agilent Technologies in a research report on Friday, June 26th. They issued an “outperform” rating and a $155.00 target price on the stock. Finally, Wells Fargo & Company cut their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the roughly $1.84 billion consensus estimate. Adjusted EPS of $1.62 exceeded estimates near $1.48-$1.49 and rose from $1.37 a year earlier. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability and cash generation strengthened. Operating profit increased 23.3% to $444 million, operating cash flow rose 43.4% to $519 million, and the company ended the quarter with $1.8 billion in cash. GAAP net income reached $362 million, or $1.28 per diluted share, versus $336 million, or $1.18, a year earlier. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Agilent raised fiscal 2026 adjusted EPS guidance to $6.18-$6.21, above the approximately $6.06 consensus, and projected revenue of about $7.5 billion versus expectations near $7.4 billion. Management cited improving laboratory-tools demand. Fourth-quarter guidance was broadly in line with analyst estimates. Agilent Raises Annual Profit Forecast
• Neutral Sentiment: Institutional investor positioning was mixed: 594 investors increased holdings in the latest quarter, while 550 reduced positions. Recent analyst targets have a median of $155, suggesting limited near-term upside relative to the recent trading level.
• Negative Sentiment: Despite the earnings beat, Agilent trades at a relatively demanding valuation, with a P/E ratio above 31, and the stock is close to its 12-month high. This could make the shares more sensitive to any slowdown in laboratory-equipment demand or future guidance disappointments.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.